Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Sangamo Therapeutics Gets European Medicines Agency PRIME Designation For Isaralgagene Civaparvovec For Treatment Of Fabry Disease

Author: Benzinga Newsdesk | February 05, 2024 03:33pm

https://www.ema.europa.eu/system/files/documents/chmp-annex/recommendations-eligibility-prime-scheme_en_0.pdf

Posted In: SGMO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist